0000899243-22-017847.txt : 20220512
0000899243-22-017847.hdr.sgml : 20220512
20220512193337
ACCESSION NUMBER: 0000899243-22-017847
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220510
FILED AS OF DATE: 20220512
DATE AS OF CHANGE: 20220512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VON ESCHENBACH ANDREW C.
CENTRAL INDEX KEY: 0001536529
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41380
FILM NUMBER: 22919646
MAIL ADDRESS:
STREET 1: BAUSCH HEALTH COMPANIES INC.
STREET 2: 400 SOMERSET CORPORATE BLVD.
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch & Lomb Corp
CENTRAL INDEX KEY: 0001860742
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 APPLEWOOD CRESCENT
CITY: VAUGHAN
STATE: A6
ZIP: L4K 4B4
BUSINESS PHONE: 908-541-5456
MAIL ADDRESS:
STREET 1: 520 APPLEWOOD CRESCENT
CITY: VAUGHAN
STATE: A6
ZIP: L4K 4B4
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-10
0
0001860742
Bausch & Lomb Corp
BLCO
0001536529
VON ESCHENBACH ANDREW C.
C/O BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT
VAUGHAN
A6
L4K 4B4
ONTARIO, CANADA
1
0
0
0
Common Shares, No Par Value
2022-05-10
4
A
0
12500
0.00
A
12500
D
Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company").
The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date.
/s/ Debra E. Levin, attorney-in-fact
2022-05-12